Turtle Cameron
Director
CIK: 1758363
All Transactions
| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| May 1, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 300 | $74.96 | $22,488.00 | View Details Filing |
| May 1, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 3,100 | $73.14 | $226,734.00 | View Details Filing |
| May 1, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 3,600 | $70.77 | $254,772.00 | View Details Filing |
| May 1, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 1,000 | $71.76 | $71,760.00 | View Details Filing |
| May 1, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 1,700 | $74.23 | $126,191.00 | View Details Filing |
| May 1, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 5,300 | $69.54 | $368,562.00 | View Details Filing |
| Apr 1, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 12,344 | $49.20 | $607,324.80 | View Details Filing |
| Apr 1, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 2,656 | $49.92 | $132,587.52 | View Details Filing |
| Mar 2, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 9,100 | $42.49 | $386,659.00 | View Details Filing |
| Mar 2, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 5,900 | $41.73 | $246,207.00 | View Details Filing |